Serious but Rare Side Effects: Pancreatitis and When to Seek Immediate Care Acute pancreatitisinflammation of the pancreasrepresents the most serious potential side effect, occurring in fewer than 1% of semaglutide users
It comes in pre-filled injection pens at fixed doses: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg
This will help minimise the risk of injection site reactions and infections
The tight junction modulating agents in present invention can be selected from: (i) Phospholipid surfactants, including dodecylphosphocholine (DPC), 1,2-didecyl phosphatidylcholine (DDPC), 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), 1-didecanoy 1-sn-glycero-3-phospho- choline (LLPC), 1,2-dioctanoyl-sn-glycero-3-phosphocholine (D8PC), 1-1-palmitoyl-2- glutaroyl-sn-glycero-3-phosphocholine (PGPC), the preferred phospholipid surfactants are DPC and DSPC, due to the better solubility and stability in liquid formulations, as well as low mucosal toxicity